Osang Healthcare Co.,Ltd (KOSDAQ:036220)
16,390
+30 (0.18%)
Sep 9, 2025, 3:30 PM KST
Osang Healthcare Co.,Ltd Revenue
Osang Healthcare Co.,Ltd had revenue of 42.03B KRW in the quarter ending June 30, 2025, with 110.19% growth. This brings the company's revenue in the last twelve months to 113.97B, up 51.31% year-over-year. In the year 2024, Osang Healthcare Co.,Ltd had annual revenue of 80.49B, down -77.38%.
Revenue (ttm)
113.97B
Revenue Growth
+51.31%
P/S Ratio
1.98
Revenue / Employee
343.28M
Employees
332
Market Cap
225.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 80.49B | -275.36B | -77.38% |
Dec 31, 2023 | 355.85B | 161.95B | 83.53% |
Dec 31, 2022 | 193.89B | 61.57B | 46.53% |
Dec 31, 2021 | 132.33B | -125.64B | -48.70% |
Dec 31, 2020 | 257.97B | 207.58B | 412.01% |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
ABL Bio | 94.93B |